波浪生命科学

最新新闻

• 评级变动
  A Quick Look at Today's Ratings for Wave Life Sciences(WVE.US), With a Forecast Between $12 to $26
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 评级变动
  A Quick Look at Today's Ratings for Wave Life Sciences(WVE.US), With a Forecast Between $13 to $15
  \u5e02\u573a\u8d44\u8baf · 2026/5/19
• 评级变动
  Mizuho Securities Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $27
  \u5e02\u573a\u8d44\u8baf · 2026/6/13
• 评级变动
  Wells Fargo Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $14
  \u5e02\u573a\u8d44\u8baf · 2026/9/10
• 评级变动
  B. Riley Securities Maintains Wave Life Sciences(WVE.US) With Buy Rating, Cuts Target Price to $22
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 评级变动
  Wedbush Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $15
  \u5e02\u573a\u8d44\u8baf · 2026/5/28
• 评级变动
  Clear Street Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $26
  \u5e02\u573a\u8d44\u8baf · 2026/8/3
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), BrightSpring Health Services, Inc. (BTSG) and AgomAb Therapeutics NV ADR (AGMB)
  TipRanks · 2026/8/3
• 评级变动
  RBC Capital Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $15
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 评级变动
  B. Riley Securities Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $31
  \u5e02\u573a\u8d44\u8baf · 2026/4/30
• 评级变动
  CCORF Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $43
  \u5e02\u573a\u8d44\u8baf · 2026/5/20
• 评级变动
  Mizuho Securities Maintains Wave Life Sciences(WVE.US) With Buy Rating, Cuts Target Price to $23
  \u5e02\u573a\u8d44\u8baf · 2026/8/3
• 评级变动
  B. Riley Securities Reaffirms Their Buy Rating on Wave Life Sciences (WVE)
  TipRanks · 2026/7/31
• 评级变动
  Wells Fargo Maintains Wave Life Sciences(WVE.US) With Buy Rating, Cuts Target Price to $14
  \u5e02\u573a\u8d44\u8baf · 2026/5/20
• 评级变动
  J.P. Morgan Initiates Wave Life Sciences(WVE.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/23
• Wedbush Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $12
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• H.C. Wainwright Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $13
  \u5e02\u573a\u8d44\u8baf · 2026/10/2
• Ladenburg Thalmann Initiates Wave Life Sciences(WVE.US) With Buy Rating, Announces Target Price $10
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• BofA Securities Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $17
  \u5e02\u573a\u8d44\u8baf · 2026/10/2
• Truist Financial Maintains Wave Life Sciences(WVE.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/10/2

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。